Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes.
about
Fed-state clamp stimulates cellular mechanisms of muscle protein anabolism and modulates glucose disposal in normal menInterplay between lipids and branched-chain amino acids in development of insulin resistanceA Metabolomic Approach to Understanding the Metabolic Link between Obesity and DiabetesA branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistancePlasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American womenSkeletal muscle and organ masses differ in overweight adults with type 2 diabetesAdiponectin signaling in the liverPlasma metabolomic profile in nonalcoholic fatty liver disease.Glutathione synthesis is diminished in patients with uncontrolled diabetes and restored by dietary supplementation with cysteine and glycineProtein metabolism in women and men: similarities and disparities.Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state.Effect of a LoBAG30 diet on protein metabolism in men with type 2 diabetes. A Randomized Controlled TrialNutritional status deteriorates as the severity of diabetic foot ulcers increases and independently associates with prognosisBranched-chain amino acids alter neurobehavioral function in ratsEffects of type 2 diabetes and insulin on whole-body, splanchnic, and leg protein metabolismInsulin resistance is associated with altered amino acid metabolism and adipose tissue dysfunction in normoglycemic women.Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian menExcessive loss of skeletal muscle mass in older adults with type 2 diabetes.Greater hand-grip strength predicts a lower risk of developing type 2 diabetes over 10 years in leaner Japanese Americans.The complex role of branched chain amino acids in diabetes and cancer.Leucine as a pharmaconutrient to prevent and treat sarcopenia and type 2 diabetes.The potential role of glutamate in the current diabetes epidemic.Dicarbonyls and Advanced Glycation End-Products in the Development of Diabetic Complications and Targets for Intervention.Prevalence and Factors Associated With Sarcopenia in Suburb-dwelling Older Chinese Using the Asian Working Group for Sarcopenia Definition.Markers of autophagy are adapted to hyperglycaemia in skeletal muscle in type 2 diabetes.Preoperative glucose and protein metabolism: the influence of diabetes mellitus type 2 in patients with colorectal tumors.Type 2 diabetes is associated with low muscle mass in older adults.Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia.Uncomplicated diabetes does not accelerate age-related sarcopenia
P2860
Q24656983-A8B4DA46-3A08-46A5-BBB6-1A8FB834FC1EQ26852310-CA902169-5D07-448A-A01B-99EF4E3415F5Q28083355-C608B23B-2557-4E78-BBAA-54DFCC3A5435Q28240815-9A401AEA-5A05-426F-9FE1-900F6C6A4101Q28476486-E2B1C276-304D-443C-99C3-9C9B6925F0D2Q34063152-35AA82B0-F40B-450B-AA1C-C7EC4EA72688Q34125349-A00E1DD7-ED2C-411D-A5B6-1B7CE672D7F2Q34180137-A85A5D0D-5A57-4A01-AB04-1E49F85CF4B3Q34422105-5BF39E3D-372B-4FCD-8B90-0A4F3BAA555CQ35223078-8127AA5F-8418-4903-A1FB-6F8A7A0A9E97Q35579562-F71547E1-3DED-49F0-B278-BF535C932364Q36237118-6A907EEC-C01C-4CD0-A210-904DDE19E3BBQ36472051-493969B2-B165-472C-9967-537ED53B3ABCQ36593081-D72799EC-E000-4C3F-92DC-CAC2C09640EEQ36666439-03136CB2-7D96-40EF-8714-C3E780009538Q36799677-25165ED0-4947-488A-A0D4-F3115F8DD1B8Q37120388-1A0018E8-7E3D-4098-8DA3-3BDBE660F9DBQ37400811-FE0D5FDB-A380-46AA-BD17-0FC8074DFE3BQ37543463-027DEB86-BFCD-4DAC-AAD0-EBD5F28C326DQ37608822-A8AF788A-7CE8-4709-9B42-B2EBBDEF8806Q37949691-D5A40369-70CA-4F79-98D7-D0E8A78D70E2Q37973276-032B5C28-0C9B-4F01-8C72-15DAF21EE1FEQ39285661-7A19D84F-D69C-4BFE-840B-48C707DF8F10Q40629142-1E25E673-7B11-42B4-820F-9E955C42C70DQ42477947-EACED211-23FF-41A1-B566-DB8AEF3F5D34Q48248546-F741D53B-36F0-49FA-A75C-2B4E8FD72CF1Q53299288-1966EFF3-5551-47CC-A668-3D5CBFC429F1Q55240540-C90665E4-D285-46E2-B671-23A49EF50344Q58140499-A0663E40-1F93-4DAC-BBFA-AB36DA519EF3
P2860
Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Determinants of whole-body pro ...... h and without type 2 diabetes.
@en
Determinants of whole-body pro ...... h and without type 2 diabetes.
@nl
type
label
Determinants of whole-body pro ...... h and without type 2 diabetes.
@en
Determinants of whole-body pro ...... h and without type 2 diabetes.
@nl
prefLabel
Determinants of whole-body pro ...... h and without type 2 diabetes.
@en
Determinants of whole-body pro ...... h and without type 2 diabetes.
@nl
P2093
P356
P1433
P1476
Determinants of whole-body pro ...... h and without type 2 diabetes.
@en
P2093
Errol B Marliss
José A Morais
Marie Lamarche
Réjeanne Gougeon
Sandra Pereira
Stéphanie Chevalier
P304
P356
10.2337/DC07-1268
P407
P577
2007-10-05T00:00:00Z